(±)-Nornicotine-d4 is a deuterium labeled (±)-Nornicotine, which is a major metabolite of Nicotine. It acts as a partial nAChRs agonist, specifically activating receptor subtypes containing α7 and α6 subunits. This compound has been shown to disrupt β-catenin and ZO-1, induce F-actin depolymerization, and support self-administration behavior.
- Can be used in research for atherosclerosis
- Can be used in research for Alzheimer's disease
- Can be used in research for schizophrenia